Frequency of ischemic cardiac events in patients receiving long-term multikinase inhibitor: A report of three cases
Long-term MKI therapy may increase the risk of severe ischemic cardiac events, likely due to accelerated atherosclerosis. Clinicians and oncology nurses should monitor patients closely for early signs of angina, especially in an outpatient setting, to prevent acute cardiac events. Further large-scale studies are warranted to establish a clearer causal relationship between MKI therapy and cardiovascular risks.
Authors
- Tomoya Yokota (ORCID: https://orcid.org/0000-0001-7327-7949)
- Nao Muraoka (ORCID: https://orcid.org/0009-0007-3564-039X)
- Hirotsugu Kenmotsu (ORCID: https://orcid.org/0000-0003-0590-9259)
- Kei Iida (ORCID: https://orcid.org/0000-0001-7130-8705)
- Takuya Oyakawa (ORCID: https://orcid.org/0000-0001-7637-5501)
- Ayano Fujita
Institutions
- Taoka Hospital (JP)
- Shizuoka Cancer Center (JP)
Publication Details
- Journal
- Asia-Pacific Journal of Oncology Nursing
- Published
- 2024-11-19
- DOI
- https://doi.org/10.1016/j.apjon.2024.100624
- Citations
- 2
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.72